A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas
Public ClinicalTrials.gov record NCT02147197. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the superiority of ulipristal acetate versus placebo for the treatment of abnormal uterine bleeding associated with uterine fibroids
Study identification
- NCT ID
- NCT02147197
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 157 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2014 (Actual)
- Primary completion
- Mar 29, 2016 (Actual)
- Completion
- Mar 29, 2016 (Actual)
- Last update posted
- Apr 30, 2019
2014 – 2016
United States locations
- U.S. sites
- 28
- U.S. states
- 18
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Watson Investigational Site 125 | Tucson | Arizona | 85710 | — |
| Watson Investigational Site 102 | San Diego | California | 92103 | — |
| Watson Investigational Site 112 | Denver | Colorado | 80209 | — |
| Watson Investigational Site 115 | Lakewood | Colorado | 80228 | — |
| Watson Investigational Site 116 | Milford | Connecticut | 06460 | — |
| Watson Investigational Site 114 | Washington D.C. | District of Columbia | 20036 | — |
| Watson Investigational Site 106 | Clearwater | Florida | 33765 | — |
| Watson Investigational Site 122 | Lake Worth | Florida | 33461 | — |
| Watson Investigational Site 130 | Miami | Florida | 33176 | — |
| Watson Investigational Site 105 | New Port Richey | Florida | 34652 | — |
| Watson Investigational Site 104 | Orlando | Florida | 32806 | — |
| Watson Investigational Site 120 | Orlando | Florida | 32806 | — |
| Watson Investigational Site 103 | Atlanta | Georgia | 30338 | — |
| Watson Investigational Site 123 | Atlanta | Georgia | 30342 | — |
| Watson Investigational Site 111 | Augusta | Georgia | 30912 | — |
| Watson Investigational Site 124 | Idaho Falls | Idaho | 83404 | — |
| Watson Investigational Site 131 | Brownsburg | Indiana | 46112 | — |
| Watson Investigational Site 129 | Shawnee Mission | Kansas | 66218 | — |
| Watson Investigational Site 132 | Metairie | Louisiana | 70006 | — |
| Watson Investigational Site 110 | Norfolk | Nebraska | 68701 | — |
| Watson Investigational Site 113 | Albuquerque | New Mexico | 87109 | — |
| Watson Investigational Site 121 | Raleigh | North Carolina | 27607 | — |
| Watson Investigational Site 109 | Winston-Salem | North Carolina | 27103 | — |
| Watson Investigational Site 107 | Columbus | Ohio | 43231 | — |
| Watson Investigational Site 119 | Jenkintown | Pennsylvania | 19046 | — |
| Watson Investigational Site 108 | Myrtle Beach | South Carolina | 29572 | — |
| Watson Investigational Site 101 | Chattanooga | Tennessee | 37404 | — |
| Watson Investigational Site 126 | Memphis | Tennessee | 38119 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02147197, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 30, 2019 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02147197 live on ClinicalTrials.gov.